Amcor plc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Amcor plc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $5.08B | Aug 15, 2025 |
| FY2025 | Mar 31, 2025 | $3.33B | Aug 15, 2025 |
| FY2025 | Dec 31, 2024 | $3.24B | Aug 15, 2025 |
| FY2025 | Sep 30, 2024 | $3.35B | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $3.54B | Aug 15, 2025 |
| FY2025 | Mar 31, 2024 | $3.41B | Aug 15, 2025 |
| FY2025 | Dec 31, 2023 | $3.25B | Aug 15, 2025 |
| FY2025 | Sep 30, 2023 | $3.44B | Aug 15, 2025 |
| FY2020 | Jun 30, 2020 | $3.14B | Aug 27, 2020 |
| FY2020 | Mar 31, 2020 | $3.14B | Aug 27, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $15.01B | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $13.64B | Aug 15, 2025 |
| FY2025 | Jun 30, 2023 | $14.69B | Aug 15, 2025 |
| FY2024 | Jun 30, 2022 | $14.54B | Aug 16, 2024 |
| FY2023 | Jun 30, 2021 | $12.86B | Aug 17, 2023 |
| FY2022 | Jun 30, 2020 | $12.47B | Aug 18, 2022 |
| FY2021 | Jun 30, 2019 | $9.46B | Aug 24, 2021 |
| FY2020 | Jun 30, 2018 | $9.32B | Aug 27, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $895.00M | Aug 15, 2025 |
| FY2025 | Mar 31, 2025 | $654.00M | Aug 15, 2025 |
| FY2025 | Dec 31, 2024 | $626.00M | Aug 15, 2025 |
| FY2025 | Sep 30, 2024 | $659.00M | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $754.00M | Aug 15, 2025 |
| FY2025 | Mar 31, 2024 | $692.00M | Aug 15, 2025 |
| FY2025 | Dec 31, 2023 | $621.00M | Aug 15, 2025 |
| FY2025 | Sep 30, 2023 | $645.00M | Aug 15, 2025 |
| FY2025 | Jun 30, 2023 | $2.73B | Aug 15, 2025 |
| FY2024 | Jun 30, 2022 | $2.82B | Aug 16, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($39.00M) | Aug 15, 2025 |
| FY2025 | Mar 31, 2025 | $196.00M | Aug 15, 2025 |
| FY2025 | Dec 31, 2024 | $163.00M | Aug 15, 2025 |
| FY2025 | Sep 30, 2024 | $191.00M | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $257.00M | Aug 15, 2025 |
| FY2025 | Mar 31, 2024 | $187.00M | Aug 15, 2025 |
| FY2025 | Dec 31, 2023 | $134.00M | Aug 15, 2025 |
| FY2025 | Sep 30, 2023 | $152.00M | Aug 15, 2025 |
| FY2025 | Jun 30, 2023 | $1.05B | Aug 15, 2025 |
| FY2024 | Jun 30, 2022 | $805.00M | Aug 16, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.01B | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $1.21B | Aug 15, 2025 |
| FY2025 | Jun 30, 2023 | $1.51B | Aug 15, 2025 |
| FY2024 | Jun 30, 2022 | $1.24B | Aug 16, 2024 |
| FY2023 | Jun 30, 2021 | $1.32B | Aug 17, 2023 |
| FY2022 | Jun 30, 2020 | $994.00M | Aug 18, 2022 |
| FY2021 | Jun 30, 2019 | $792.00M | Aug 24, 2021 |
| FY2020 | Jun 30, 2018 | $993.90M | Aug 27, 2020 |
| FY2019 | Jun 30, 2017 | $916.10M | Sep 3, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $120.00M | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $106.00M | Aug 15, 2025 |
| FY2025 | Jun 30, 2023 | $101.00M | Aug 15, 2025 |
| FY2024 | Jun 30, 2022 | $96.00M | Aug 16, 2024 |
| FY2023 | Jun 30, 2021 | $100.00M | Aug 17, 2023 |
| FY2022 | Jun 30, 2020 | $97.00M | Aug 18, 2022 |
| FY2021 | Jun 30, 2019 | $64.00M | Aug 24, 2021 |
| FY2020 | Jun 30, 2018 | $72.70M | Aug 27, 2020 |
| FY2019 | Jun 30, 2017 | $69.10M | Sep 3, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.21B | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $1.09B | Aug 15, 2025 |
| FY2025 | Jun 30, 2023 | $1.09B | Aug 15, 2025 |
| FY2024 | Jun 30, 2022 | $1.28B | Aug 16, 2024 |
| FY2023 | Jun 30, 2021 | $1.29B | Aug 17, 2023 |
| FY2022 | Jun 30, 2020 | $1.39B | Aug 18, 2022 |
| FY2021 | Jun 30, 2019 | $999.00M | Aug 24, 2021 |
| FY2020 | Jun 30, 2018 | $793.20M | Aug 27, 2020 |
| FY2019 | Jun 30, 2017 | $850.20M | Sep 3, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.39B | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $1.32B | Aug 15, 2025 |
| FY2025 | Jun 30, 2023 | $1.26B | Aug 15, 2025 |
| FY2024 | Jun 30, 2022 | $1.53B | Aug 16, 2024 |
| FY2023 | Jun 30, 2021 | $1.46B | Aug 17, 2023 |
| FY2022 | Jun 30, 2020 | $1.38B | Aug 18, 2022 |
| FY2021 | Jun 30, 2019 | $776.00M | Aug 24, 2021 |
| FY2020 | Jun 30, 2018 | $871.40M | Aug 27, 2020 |
| FY2019 | Jun 30, 2017 | $908.90M | Sep 3, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Jun 30, 2019 | $332.20M | Sep 3, 2019 |
| FY2019 | Jun 30, 2018 | $365.00M | Sep 3, 2019 |
| FY2019 | Jun 30, 2017 | $379.30M | Sep 3, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $37.07B | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $16.52B | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | $17.00B | Aug 16, 2024 |
| FY2023 | Jun 30, 2022 | $17.43B | Aug 17, 2023 |
| FY2022 | Jun 30, 2021 | $17.19B | Aug 18, 2022 |
| FY2021 | Jun 30, 2020 | $16.44B | Aug 24, 2021 |
| FY2020 | Jun 30, 2019 | $17.17B | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | $9.06B | Sep 3, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $25.33B | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $12.57B | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | $12.91B | Aug 16, 2024 |
| FY2023 | Jun 30, 2022 | $13.29B | Aug 17, 2023 |
| FY2022 | Jun 30, 2021 | $12.37B | Aug 18, 2022 |
| FY2021 | Jun 30, 2020 | $11.76B | Aug 24, 2021 |
| FY2020 | Jun 30, 2019 | $11.49B | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | $8.36B | Sep 3, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $11.73B | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $3.88B | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | $4.03B | Aug 16, 2024 |
| FY2023 | Jun 30, 2022 | $4.08B | Aug 17, 2023 |
| FY2022 | Jun 30, 2021 | $4.76B | Aug 18, 2022 |
| FY2021 | Jun 30, 2020 | $4.63B | Aug 24, 2021 |
| FY2020 | Jun 30, 2019 | $5.61B | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | $626.60M | Sep 3, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $11.28B | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $5.35B | Aug 15, 2025 |
| FY2025 | Jun 30, 2023 | $5.37B | Aug 15, 2025 |
| FY2024 | Jun 30, 2022 | $5.29B | Aug 16, 2024 |
| FY2023 | Jun 30, 2021 | $5.42B | Aug 17, 2023 |
| FY2022 | Jun 30, 2020 | $5.34B | Aug 18, 2022 |
| FY2021 | Jun 30, 2019 | $5.16B | Aug 24, 2021 |
| FY2020 | Jun 30, 2018 | $2.06B | Aug 27, 2020 |
| FY2019 | Jun 30, 2017 | $2.06B | Sep 3, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $548.00M | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $879.00M | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | $865.00M | Aug 16, 2024 |
| FY2023 | Jun 30, 2022 | $534.00M | Aug 17, 2023 |
| FY2022 | Jun 30, 2021 | $452.00M | Aug 18, 2022 |
| FY2021 | Jul 1, 2020 | $241.00M | Aug 24, 2021 |
| FY2021 | Jun 30, 2020 | $246.00M | Aug 24, 2021 |
| FY2020 | Jul 1, 2019 | $381.90M | Aug 27, 2020 |
| FY2020 | Jun 30, 2019 | $323.70M | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | $561.40M | Sep 3, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $827.00M | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $588.00M | Aug 15, 2025 |
| FY2024 | Jun 30, 2023 | $689.00M | Aug 16, 2024 |
| FY2023 | Jun 30, 2022 | $775.00M | Aug 17, 2023 |
| FY2022 | Jun 30, 2021 | $850.00M | Aug 18, 2022 |
| FY2021 | Jun 30, 2020 | $743.00M | Aug 24, 2021 |
| FY2020 | Jun 30, 2019 | $601.60M | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | $620.80M | Sep 3, 2019 |
| FY2019 | Jun 30, 2017 | $561.50M | Sep 3, 2019 |
| FY2019 | Jun 30, 2016 | $515.70M | Sep 3, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Jun 30, 2019 | $5.31B | Sep 3, 2019 |
| FY2019 | Jun 30, 2018 | $3.67B | Sep 3, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Aug 15, 2025 |
| FY2025 | Mar 31, 2025 | 0 | Aug 15, 2025 |
| FY2025 | Dec 31, 2024 | 0 | Aug 15, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Aug 15, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Aug 15, 2025 |
| FY2025 | Dec 31, 2023 | 0 | Aug 15, 2025 |
| FY2025 | Sep 30, 2023 | 0 | Aug 15, 2025 |
| FY2025 | Jun 30, 2023 | 0 | Aug 15, 2025 |
| FY2024 | Jun 30, 2022 | 0 | Aug 16, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Aug 15, 2025 |
| FY2025 | Jun 30, 2023 | 0 | Aug 15, 2025 |
| FY2024 | Jun 30, 2022 | 0 | Aug 16, 2024 |
| FY2023 | Jun 30, 2021 | 0 | Aug 17, 2023 |
| FY2020 | Jun 30, 2020 | 0 | Aug 27, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 27, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Aug 27, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Aug 27, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 27, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $845.00M | Aug 15, 2025 |
| FY2025 | Jun 30, 2024 | $722.00M | Aug 15, 2025 |
| FY2025 | Jun 30, 2023 | $723.00M | Aug 15, 2025 |
| FY2024 | Jun 30, 2022 | $732.00M | Aug 16, 2024 |
| FY2023 | Jun 30, 2021 | $742.00M | Aug 17, 2023 |
| FY2022 | Jun 30, 2020 | $761.00M | Aug 18, 2022 |
| FY2021 | Jun 30, 2019 | $680.00M | Aug 24, 2021 |
| FY2020 | Jun 30, 2018 | $526.80M | Aug 27, 2020 |
| FY2019 | Jun 30, 2017 | $489.10M | Sep 3, 2019 |